Editorial: Clinical implications of the molecular basis of familial hypercholesterolemia and other inherited dyslipidemias

Circulation

Volumn 123, Issue 11, 2011, Pages 1153-1155

  Kwiterovich, Peter O ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b David Rubenstein Building ^*  (United States)

Author keywords

apolipoproteins B; cholesterol reduction; Editorials; familial combined; familial hypercholesterolemia; genetics; hyperlipidemia; low density lipoprotein (LDL) cholesterol

Indexed keywords

APOLIPOPROTEIN B; EZETIMIBE; KEXIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; PLACEBO; PRAVASTATIN; CHOLESTEROL;

AUTOSOMAL DOMINANT HYPERCHOLESTEROLEMIA; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; EDITORIAL; HYPERCHOLESTEROLEMIA; OBESITY; PHENOTYPE; PRIORITY JOURNAL; ADOLESCENT; BLOOD; CHILD; DYSLIPIDEMIA; GENETICS; HUMAN; HYPERLIPOPROTEINEMIA TYPE 2; MUTATION; NOTE; PRESCHOOL CHILD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHOLESTEROL; CHOLESTEROL, LDL; DYSLIPIDEMIAS; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MUTATION; RECEPTORS, LDL;

EID: 79953045746     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.111.021857     Document Type: Editorial

References (20)

1. Van der Graaf A, Avis HJ, Kusters DM, Vissers MN, Hutten BA, Defesche JP, Huijgen R, Fouchier SW, Wijburg FA, Kastelein JJP, Wiegman A. Molecular basis of autosomal dominant hypercholesterolemia: assessment in a large cohort of hypercholesterolemic children. Circulation. 2011;123:1167-1173.
2. Campagna F, Martino F, Bifolco M, Montali A, Martino E, Morrone F, Antonini R, Cantafora A, Verna R, Arca M. Detection of familial hypercholesterolemia in a cohort of children with hypercholesterolemia: results of a family and DNA-based screening. Atherosclerosis. 2008;196:356-364.
3. Punzalan FE, Sy RG, Santos RS, Cutiongco EM, Gosiengfiao S, Fadriguilan E, George P, Laurie A. Low density lipoprotein-receptor (LDL-R) gene mutations among Filipinos with familial hypercholesterolemia. J Atheroscler Thromb. 2005;12:276-283.
4. Damgaard D, Larsen ML, Nissen PH, Jensen JM, Jensen HK, Soerensen VR, Jensen LG, Faergeman O. The relationship of molecular genetic to clinical diagnosis of familial hypercholesterolemia in a Danish population. Atherosclerosis. 2005;180:155-160.
5. Graham CA, Mcllhatton BP, Kirk CW, Beattie ED, Lyttle K, Hart P, Neely RD, Young IS, Nicholls DP. Genetic screening protocol for familial hypercholesterolemia which includes splicing defects gives an improved mutation detection rate. Atherosclerosis. 2005;182:331-340. (Pubitemid 41267202)
6. Assouline L, Levy E, Feoli-Fonseca JC, Godbout C, Lambert M. Familial hypercholesterolemia: molecular, biochemical, and clinical character- ization of a French-Canadian pediatric population. Pediatrics. 1995;96: 239-246.
7. Rader DJ, Cohen J, Hobbs HH. Monogenic hypercholesterolemia: new insights in pathogenesis and treatment. J Clin Invest. 2003;111: 1795-1803. (Pubitemid 38057721)
8. Kwiterovich PO Jr. Recognition and management of dyslipidemia in children and adolescents. J Clin Endocrinol Metab. 2008;4200-4209. (Pubitemid 352789511)
9. Avis HJ, Vissers MN, Stein EA, Wijburg FA, Trip MD, Kastelein JJ, Hutten BA. A systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol. 2007;27:1803-1810. (Pubitemid 47207177)
10. Wiegman A, Hutton BA, de Groot E, Rodenberg J, Bakker HD, Büller HR, Sijbrands EJ, Kastelein JJ. Efficacy and safety in children with hypercholesterolemia: a randomized controlled trial. JAMA. 2004;292:331-337. (Pubitemid 38944256)
11. Rodenburg J, Vissers MN, Wiegman A, van Trotsenburg AS, van der Graaf A, de Groot E, Wijburg FA, Kastelein JJ, Hutten BA. Statin treatment in children with familial hypercholesterolemia: the younger, the better. Circulation. 2007;116:664-668. (Pubitemid 47356351)
12. Daniels SR, Greer FR; Committee on Nutrition. Lipid screening and cardiovascular health in childhood. Pediatrics. 2008;122:198-208.
13. Van der Graaf A, Cuffie-Jackson C, Vissers MN, Trip MD, Cagné C, Shi G, Veltri E, Avis HJ, Kastelein JJ. Efficacy and safety of coadministration of ezetimibe and simvastatin in adolescents with heterozygous familial hypercholesterolemia. J Am Coll Cardiol. 2008;52:1421-1429.
14. Wald DS, Bestwick JP, Wald NJ. Child-parent screening for familial hypercholesterolemia: screening strategy based on a meta-analysis. BMJ. 2007;335:599-607.
15. Kwiterovich PO Jr, Fredrickson DS, Levy RI. Familial hypercholesterolemia (one form of type II hyperlipoproteinemia): A study of its biochemical, clinical and genetic presentation in childhood. J Clin Invest. 1974;53:1237-1249.
16. Kwiterovich PO Jr, Barton BA, McMahon RP, Obarzanek E, Hunsberger S, Simons-Morton D, Kimm SY, Friedman LA, Lasser N, Robson A, Lauer R, Stevens V, Van Horn L, Gidding S, Snetselaar L, Hartmuller VW, Greenlick M, Franklin F Jr. Effect of diet and sexual maturation on low-density lipoprotein cholesterol during puberty: the Dietary Intervention Study in Children (DISC). Circulation. 1997;96:2526-2533. (Pubitemid 27451341)
17. Kwiterovich PO Jr. Cut points for children and adolescents: should they be reassessed? Clin Chem. 2008;54:1113-1115.
18. Srinivasan SR, Myers L, Berenson GS. Distribution and correlates of non-high-density lipoprotein cholesterol in children: the Bogalusa Heart Study. Pediatrics. 2002;110:e29.
19. Cortner JA, Coates PM, Gallagher PR. Prevalence and expression of familial combined hyperlipidemia in childhood. J Pediatr. 1990;116: 514-519. (Pubitemid 20124144)
20. ter Avest E, Sniderman AD, Bredie SJ, Wiegman A, Stalenhoef AF, de Graaf J. Effects of aging and obesity on the expression of dyslipidaemia in children from families with familial combined hyperlipidaemia. Clin Sci (Lond.). 2007;112:131-139. (Pubitemid 46120092)